Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
TNF-α mediates SDF-1α–induced NF-κB activation and cytotoxic effects in primary astrocytes
Yulong Han, Tao He, DeRen Huang, Carlos A. Pardo, Richard M. Ransohoff
Yulong Han, Tao He, DeRen Huang, Carlos A. Pardo, Richard M. Ransohoff
View: Text | PDF
Article

TNF-α mediates SDF-1α–induced NF-κB activation and cytotoxic effects in primary astrocytes

  • Text
  • PDF
Abstract

Stromal-derived cell factor-1α (SDF-1α; CXCL12) and its receptor, CXCR4, are constitutively expressed on neuroepithelial cells and are believed to be involved in both development and pathological processes, such as AIDS-associated neurologic disorders. Here, we demonstrate that SDF-1α activates NF-κB, stimulates production of chemokines and cytokines, and induces cell death in primary astrocytes, effects that depend on ongoing secretion of TNF-α. SDF-1α upregulated TNF-α mRNA and protein secretion, as well as TNF receptor 2 expression. TNF-α treatment mimicked SDF-1α induction of NF-κB, IL-1α/β, and RANTES, as well as cell death; neutralizing antibodies against TNF-α opposed these responses. We also found that SDF-1α activated Erk1 and Erk2 (Erk1/2) MAPK in a biphasic fashion. Early Erk1/2 activation was stimulated directly by SDF-1α and late activation was mediated by TNF-α. PD98059 suppression of early Erk1/2 activation correlated with reduction of SDF-1α–induced TNF-α expression. Late Erk1/2 activation was involved in TNF-α–stimulated NF-κB activation and cytokine induction. SDF-1α was induced in reactive CXCR4-positive astrocytes near axotomized spinal cord motor neurons, consistent with autocrine SDF-1/CXCR4 signaling in these cells. We propose that these novel effects of SDF-1α are relevant to the pathogenic and developmental roles of SDF-1α in the CNS.

Authors

Yulong Han, Tao He, DeRen Huang, Carlos A. Pardo, Richard M. Ransohoff

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
TNF-α mediates SDF-1α–induced astrocyte cell death. Confluent astrocytes...
TNF-α mediates SDF-1α–induced astrocyte cell death. Confluent astrocytes in 12-well plates were incubated with SDF-1α, TNF-α, or SDF-1α plus anti–TNF-α antibodies (2 μg/ml) for 3 days; or exposed to H2O2 (100 μM) for 30 minutes followed by incubation with normal medium for 3 days; and then an MTT activity assay was performed. Mean ± SD of MTT activity obtained from triplicate treatments is shown (Student’s t test: *SDF-1α treatment vs. untreated control, P < 0.001; **H2O2 treatment vs. untreated control, P < 0.001; #TNF-α treatment vs. untreated control, P < 0.001; ##treatment with anti–TNF-α antibody + SDF-1α vs. SDF-1α alone, P = 0.0058). Untreated control was plotted as 100%. Data represent three experiments.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts